Global Drug of Abuse Testing Services Market, By Drug Type, By Technique, By End User, By Region & Segmental Insights Trends and Forecast, 2023 – 2031

  • Industry: Healthcare
  • Report ID: TNR-110-1029
  • Number of Pages: 420
  • Table/Charts : Yes
  • November, 2023
  • Base Year : 2024
  • No. of Companies : 12+
  • No. of Countries : 29
  • Views : 10077
  • Covid Impact Covered: Yes
  • War Impact Covered: Yes
  • Formats : PDF, Excel, PPT

Drug of abuse testing services refers to professional laboratory testing for the presence of illicit drugs or the misuse of prescription medications in an individual’s body fluids, typically urine, blood, or saliva. These services are used by employers, law enforcement, healthcare providers, and individuals to monitor substance use and ensure compliance with drug policies or treatment programs. In terms of revenue, the global drug of abuse testing services market was worth US$ 6.41 Bn in 2022, anticipated to witness CAGR of 3.5% during 2023 – 2031.

Global Drug of Abuse Testing Services Market Revenue & Forecast, (US$ Million), 2015 – 2031

Trends in the Global Drug of Abuse Testing Services Market

  • Currently, there is a notable increase in the demand for workplace drug testing services. Many organizations are implementing stricter drug testing policies to ensure a drug-free and safe work environment. This trend is driven by the need to mitigate risks associated with drug-related incidents, reduce accidents, and enhance productivity. The ongoing emphasis on maintaining a drug-free workforce has led to a continuous uptick in the adoption of drug testing services by employers across various industries.
  • Presently, the opioid epidemic is a major driver for drug testing services. There is a heightened awareness of the widespread misuse of prescription opioids and illicit drugs, leading to increased demand for testing to combat this public health crisis. Healthcare providers, addiction treatment centers, and law enforcement agencies are actively utilizing drug testing to identify and assist individuals struggling with opioid addiction. This trend highlights the pivotal role of drug testing services in addressing the opioid epidemic and ensuring appropriate intervention and support for affected individuals.

Cannabinoids segment has gained popularity in recent years and is anticipated to be the fastest growing segment in the global drug of abuse testing services market during the forecast period. This reflects the changing landscape of drug policies worldwide. With the increasing legalization of cannabis for medical and recreational purposes in various regions, there’s a growing need for testing services to monitor THC (tetrahydrocannabinol) levels. For instance, in the US, over 40 states have legalized some form of cannabis use. This trend has led to a surge in demand for accurate and reliable cannabinoid testing, especially in workplaces and law enforcement. As cannabis-related regulations evolve, the cannabinoids segment is experiencing rapid expansion within the drug testing services market.

Immunoassay technique segment had the highest share in the global drug of abuse testing services market in 2022. The dominance can be attributed to its widespread use, cost-effectiveness, and rapid results. Immunoassay techniques, such as enzyme-linked immunosorbent assays (ELISA), are widely employed for their efficiency in detecting a broad range of drugs in various bodily fluids. For example, in the US workplace drug testing, immunoassays are the initial screening method, covering substances like opioids, cannabinoids, amphetamines, and cocaine. Their speed and cost-efficiency make them the preferred choice for high-volume drug testing. Immunoassays play a pivotal role in the drug testing landscape, ensuring accurate and timely results for diverse stakeholders.

North America dominated the drug of abuse testing services market in 2022 due to several key factors. Firstly, the region faces significant substance abuse challenges, with opioid addiction being a major concern. For example, in the US, opioid overdose deaths reached over 93,000 in 2020. This crisis drives the demand for drug testing services in healthcare, addiction treatment, and law enforcement. Secondly, stringent workplace drug testing regulations in North America are contributing to the sustained demand for these services. Moreover, the presence of established pharmaceutical and diagnostic companies, along with advanced healthcare infrastructure, further solidifies North America’s leadership in drug testing services.

Competitive Landscape: Global Drug of Abuse Testing Services Market

  • Abbott
  • American Substance Abuse Professionals, Inc.
  • Clinical Reference Laboratory, Inc.
  • Cordant Health Solutions
  • DRUGSCAN
  • Laboratory Corporation of America Holdings
  • Legacy Medical Services, LLC
  • LGC Limited
  • Mayo Foundation for Medical Education and Research
  • Millennium Health
  • Omega Laboratories, Inc.
  • Precision Diagnostics
  • Psychemedics Corporation
  • Quest Diagnostics
  • United States Drug Testing Laboratories, Inc.
  • Other Industry Participants

Global Drug of Abuse Testing Services Market Key Takeaways

 

Report Specifications Details
Market Revenue in 2022 US$ 6.41 Bn
Market Size Forecast by 2031 US$ 9.45 Bn
Growth Rate (CAGR) 3.5%
Historic Data 2015 – 2021
Base Year for Estimation 2022
Forecast Period 2023 – 2031
Report Inclusions Market Size & Estimates, Market Dynamics, Competitive Scenario, Trends, Growth Factors, Market Determinants, Key Investment Segmentation, Product/Service/Solutions Benchmarking
Segments Covered By Drug Type, By Technique, By End User
Regions Covered North America, Europe, Asia Pacific, Middle East & Africa, Latin America
Countries Covered U.S., Canada, Mexico, Rest of North America,  France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe,  China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific,  Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa,  Brazil, Argentina, Rest of Latin America
Key Players Abbott, American Substance Abuse Professionals, Inc., Clinical Reference Laboratory, Inc., Cordant Health Solutions, DRUGSCAN, Laboratory Corporation of America Holdings, Legacy Medical Services, LLC, LGC Limited, Mayo Foundation for Medical Education and Research, Millennium Health, Omega Laboratories, Inc., Precision Diagnostics, Psychemedics Corporation, Quest Diagnostics, United States Drug Testing Laboratories, Inc., Other market participants
Customization Scope Customization allows for the inclusion/modification of content pertaining to geographical regions, countries, and specific market segments.
Pricing & Procurement Options Explore purchase options tailored to your specific research requirements
Contact Details Consult With Our Expert

Japan (Toll-Free):  +81 663-386-8111

South Korea (Toll-Free):  +82-808- 703-126

Saudi Arabia (Toll-Free):  +966 800-850-1643

United Kingdom: +44 753-710-5080

United States: +1 302-232-5106

E-mail:  askanexpert@thenicheresearch.com

 

Report Snapshot

Global Drug of Abuse Testing Services Market

By Drug Type

  • Pyschostimulants
  • Narcotic
  • Cannabinoids
  • Sedatives
  • Others

By Technique

  • Immunoassay
  • Chromatography
  • Rapid Testing

By End User

  • Hospitals
  • Diagnostics Laboratories
  • Forensic Laboratories
  • Others

By Region

  • North America (U.S., Canada, Mexico, Rest of North America)
  • Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
  • Latin America (Brazil, Argentina, Rest of Latin America)

Table of Contents

.

1.Market Scope
1.1.Market Segmentation
1.2.Years Considered
1.2.1.Historic Years: 2015 - 2021
1.2.2.Base Year: 2022
1.2.3.Forecast Years: 2023 – 2031
2.Key Target Audiences
3.Research Methodology
3.1.Primary Research
3.1.1.Research Questionnaire
3.1.2.Global Percentage Breakdown
3.1.3.Primary Interviews: Key Opinion Leaders (KOLs)
3.2.Secondary Research
3.2.1.Paid Databases
3.2.2.Secondary Sources
3.3.Market Size Estimates
3.3.1.Top-Down Approach
3.3.2.Bottom-Up Approach
3.4.Data Triangulation Methodology
3.5.Research Assumptions
4.Recommendations and Insights from TNR’s Perspective**
5.Holistic Overview of Drug of Abuse Testing Services Market
6.Market Synopsis: Drug of Abuse Testing Services Market
7.Drug of Abuse Testing Services Market Analysis: Qualitative Perspective
7.1.Introduction
7.1.1.Product Definition
7.1.2.Industry Development
7.2.Market Dynamics
7.2.1.Drivers
7.2.2.Restraints
7.2.3.Opportunities
7.2.4.Challenges
7.3.Trends in Drug of Abuse Testing Services Market
7.4.Market Determinants Radar Chart
7.5.Macro-Economic and Micro-Economic Indicators: Drug of Abuse Testing Services Market
7.6.Porter’s Five Force Analysis
7.7.Impact of Covid-19 on Drug of Abuse Testing Services Market
8.Global Drug of Abuse Testing Services Market Analysis and Forecasts, 2023 - 2031
8.1.Overview
8.1.1.Global Drug of Abuse Testing Services Market Revenue (US$ Mn)
8.2.Global Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
8.2.1.Pyschostimulants
8.2.1.1.Definition
8.2.1.2.Market Estimation and Penetration, 2015 - 2022
8.2.1.3.Market Forecast, 2023 - 2031
8.2.1.4.Compound Annual Growth Rate (CAGR)
8.2.1.5.Regional Bifurcation
8.2.1.5.1.North America
8.2.1.5.1.1.Market Estimation, 2015 - 2022
8.2.1.5.1.2.Market Forecast, 2023 - 2031
8.2.1.5.2.Europe
8.2.1.5.2.1.Market Estimation, 2015 - 2022
8.2.1.5.2.2.Market Forecast, 2023 - 2031
8.2.1.5.3.Asia Pacific
8.2.1.5.3.1.Market Estimation, 2015 - 2022
8.2.1.5.3.2.Market Forecast, 2023 - 2031
8.2.1.5.4.Middle East and Africa
8.2.1.5.4.1.Market Estimation, 2015 - 2022
8.2.1.5.4.2.Market Forecast, 2023 - 2031
8.2.1.5.5.Latin America
8.2.1.5.5.1.Market Estimation, 2015 - 2022
8.2.1.5.5.2.Market Forecast, 2023 - 2031
8.2.2.Narcotics
8.2.2.1.Definition
8.2.2.2.Market Estimation and Penetration, 2015 - 2022
8.2.2.3.Market Forecast, 2023 - 2031
8.2.2.4.Compound Annual Growth Rate (CAGR)
8.2.2.5.Regional Bifurcation
8.2.2.5.1.North America
8.2.2.5.1.1.Market Estimation, 2015 - 2022
8.2.2.5.1.2.Market Forecast, 2023 - 2031
8.2.2.5.2.Europe
8.2.2.5.2.1.Market Estimation, 2015 - 2022
8.2.2.5.2.2.Market Forecast, 2023 - 2031
8.2.2.5.3.Asia Pacific
8.2.2.5.3.1.Market Estimation, 2015 - 2022
8.2.2.5.3.2.Market Forecast, 2023 - 2031
8.2.2.5.4.Middle East and Africa
8.2.2.5.4.1.Market Estimation, 2015 - 2022
8.2.2.5.4.2.Market Forecast, 2023 - 2031
8.2.2.5.5.Latin America
8.2.2.5.5.1.Market Estimation, 2015 - 2022
8.2.2.5.5.2.Market Forecast, 2023 - 2031
8.2.3.Cannabinoids
8.2.3.1.Definition
8.2.3.2.Market Estimation and Penetration, 2015 - 2022
8.2.3.3.Market Forecast, 2023 - 2031
8.2.3.4.Compound Annual Growth Rate (CAGR)
8.2.3.5.Regional Bifurcation
8.2.3.5.1.North America
8.2.3.5.1.1.Market Estimation, 2015 - 2022
8.2.3.5.1.2.Market Forecast, 2023 - 2031
8.2.3.5.2.Europe
8.2.3.5.2.1.Market Estimation, 2015 - 2022
8.2.3.5.2.2.Market Forecast, 2023 - 2031
8.2.3.5.3.Asia Pacific
8.2.3.5.3.1.Market Estimation, 2015 - 2022
8.2.3.5.3.2.Market Forecast, 2023 - 2031
8.2.3.5.4.Middle East and Africa
8.2.3.5.4.1.Market Estimation, 2015 - 2022
8.2.3.5.4.2.Market Forecast, 2023 - 2031
8.2.3.5.5.Latin America
8.2.3.5.5.1.Market Estimation, 2015 - 2022
8.2.3.5.5.2.Market Forecast, 2023 - 2031
8.2.4.Sedatives
8.2.4.1.Definition
8.2.4.2.Market Estimation and Penetration, 2015 - 2022
8.2.4.3.Market Forecast, 2023 - 2031
8.2.4.4.Compound Annual Growth Rate (CAGR)
8.2.4.5.Regional Bifurcation
8.2.4.5.1.North America
8.2.4.5.1.1.Market Estimation, 2015 - 2022
8.2.4.5.1.2.Market Forecast, 2023 - 2031
8.2.4.5.2.Europe
8.2.4.5.2.1.Market Estimation, 2015 - 2022
8.2.4.5.2.2.Market Forecast, 2023 - 2031
8.2.4.5.3.Asia Pacific
8.2.4.5.3.1.Market Estimation, 2015 - 2022
8.2.4.5.3.2.Market Forecast, 2023 - 2031
8.2.4.5.4.Middle East and Africa
8.2.4.5.4.1.Market Estimation, 2015 - 2022
8.2.4.5.4.2.Market Forecast, 2023 - 2031
8.2.4.5.5.Latin America
8.2.4.5.5.1.Market Estimation, 2015 - 2022
8.2.4.5.5.2.Market Forecast, 2023 - 2031
8.2.5.Others
8.2.5.1.Definition
8.2.5.2.Market Estimation and Penetration, 2015 - 2022
8.2.5.3.Market Forecast, 2023 - 2031
8.2.5.4.Compound Annual Growth Rate (CAGR)
8.2.5.5.Regional Bifurcation
8.2.5.5.1.North America
8.2.5.5.1.1.Market Estimation, 2015 - 2022
8.2.5.5.1.2.Market Forecast, 2023 - 2031
8.2.5.5.2.Europe
8.2.5.5.2.1.Market Estimation, 2015 - 2022
8.2.5.5.2.2.Market Forecast, 2023 - 2031
8.2.5.5.3.Asia Pacific
8.2.5.5.3.1.Market Estimation, 2015 - 2022
8.2.5.5.3.2.Market Forecast, 2023 - 2031
8.2.5.5.4.Middle East and Africa
8.2.5.5.4.1.Market Estimation, 2015 - 2022
8.2.5.5.4.2.Market Forecast, 2023 - 2031
8.2.5.5.5.Latin America
8.2.5.5.5.1.Market Estimation, 2015 - 2022
8.2.5.5.5.2.Market Forecast, 2023 - 2031
8.3.Key Segment for Channeling Investments
8.3.1.By Drug Type
9.Global Drug of Abuse Testing Services Market Analysis and Forecasts, 2023 - 2031
9.1.Overview
9.2.Global Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
9.2.1.Immunoassay
9.2.1.1.Definition
9.2.1.2.Market Estimation and Penetration, 2015 - 2022
9.2.1.3.Market Forecast, 2023 - 2031
9.2.1.4.Compound Annual Growth Rate (CAGR)
9.2.1.5.Regional Bifurcation
9.2.1.5.1.North America
9.2.1.5.1.1.Market Estimation, 2015 - 2022
9.2.1.5.1.2.Market Forecast, 2023 - 2031
9.2.1.5.2.Europe
9.2.1.5.2.1.Market Estimation, 2015 - 2022
9.2.1.5.2.2.Market Forecast, 2023 - 2031
9.2.1.5.3.Asia Pacific
9.2.1.5.3.1.Market Estimation, 2015 - 2022
9.2.1.5.3.2.Market Forecast, 2023 - 2031
9.2.1.5.4.Middle East and Africa
9.2.1.5.4.1.Market Estimation, 2015 - 2022
9.2.1.5.4.2.Market Forecast, 2023 - 2031
9.2.1.5.5.Latin America
9.2.1.5.5.1.Market Estimation, 2015 - 2022
9.2.1.5.5.2.Market Forecast, 2023 - 2031
9.2.2.Chromatography
9.2.2.1.Definition
9.2.2.2.Market Estimation and Penetration, 2015 - 2022
9.2.2.3.Market Forecast, 2023 - 2031
9.2.2.4.Compound Annual Growth Rate (CAGR)
9.2.2.5.Regional Bifurcation
9.2.2.5.1.North America
9.2.2.5.1.1.Market Estimation, 2015 - 2022
9.2.2.5.1.2.Market Forecast, 2023 - 2031
9.2.2.5.2.Europe
9.2.2.5.2.1.Market Estimation, 2015 - 2022
9.2.2.5.2.2.Market Forecast, 2023 - 2031
9.2.2.5.3.Asia Pacific
9.2.2.5.3.1.Market Estimation, 2015 - 2022
9.2.2.5.3.2.Market Forecast, 2023 - 2031
9.2.2.5.4.Middle East and Africa
9.2.2.5.4.1.Market Estimation, 2015 - 2022
9.2.2.5.4.2.Market Forecast, 2023 - 2031
9.2.2.5.5.Latin America
9.2.2.5.5.1.Market Estimation, 2015 - 2022
9.2.2.5.5.2.Market Forecast, 2023 - 2031
9.2.3.Rapid Testing
9.2.3.1.Definition
9.2.3.2.Market Estimation and Penetration, 2015 - 2022
9.2.3.3.Market Forecast, 2023 - 2031
9.2.3.4.Compound Annual Growth Rate (CAGR)
9.2.3.5.Regional Bifurcation
9.2.3.5.1.North America
9.2.3.5.1.1.Market Estimation, 2015 - 2022
9.2.3.5.1.2.Market Forecast, 2023 - 2031
9.2.3.5.2.Europe
9.2.3.5.2.1.Market Estimation, 2015 - 2022
9.2.3.5.2.2.Market Forecast, 2023 - 2031
9.2.3.5.3.Asia Pacific
9.2.3.5.3.1.Market Estimation, 2015 - 2022
9.2.3.5.3.2.Market Forecast, 2023 - 2031
9.2.3.5.4.Middle East and Africa
9.2.3.5.4.1.Market Estimation, 2015 - 2022
9.2.3.5.4.2.Market Forecast, 2023 - 2031
9.2.3.5.5.Latin America
9.2.3.5.5.1.Market Estimation, 2015 - 2022
9.2.3.5.5.2.Market Forecast, 2023 - 2031
9.3.Key Segment for Channeling Investments
9.3.1.By Technique
10.Global Drug of Abuse Testing Services Market Analysis and Forecasts, 2023 - 2031
10.1.Overview
10.2.Global Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
10.2.1.Hospitals
10.2.1.1.Definition
10.2.1.2.Market Estimation and Penetration, 2015 - 2022
10.2.1.3.Market Forecast, 2023 - 2031
10.2.1.4.Compound Annual Growth Rate (CAGR)
10.2.1.5.Regional Bifurcation
10.2.1.5.1.North America
10.2.1.5.1.1.Market Estimation, 2015 - 2022
10.2.1.5.1.2.Market Forecast, 2023 - 2031
10.2.1.5.2.Europe
10.2.1.5.2.1.Market Estimation, 2015 - 2022
10.2.1.5.2.2.Market Forecast, 2023 - 2031
10.2.1.5.3.Asia Pacific
10.2.1.5.3.1.Market Estimation, 2015 - 2022
10.2.1.5.3.2.Market Forecast, 2023 - 2031
10.2.1.5.4.Middle East and Africa
10.2.1.5.4.1.Market Estimation, 2015 - 2022
10.2.1.5.4.2.Market Forecast, 2023 - 2031
10.2.1.5.5.Latin America
10.2.1.5.5.1.Market Estimation, 2015 - 2022
10.2.1.5.5.2.Market Forecast, 2023 - 2031
10.2.2.Diagnostics Laboratories
10.2.2.1.Definition
10.2.2.2.Market Estimation and Penetration, 2015 - 2022
10.2.2.3.Market Forecast, 2023 - 2031
10.2.2.4.Compound Annual Growth Rate (CAGR)
10.2.2.5.Regional Bifurcation
10.2.2.5.1.North America
10.2.2.5.1.1.Market Estimation, 2015 - 2022
10.2.2.5.1.2.Market Forecast, 2023 - 2031
10.2.2.5.2.Europe
10.2.2.5.2.1.Market Estimation, 2015 - 2022
10.2.2.5.2.2.Market Forecast, 2023 - 2031
10.2.2.5.3.Asia Pacific
10.2.2.5.3.1.Market Estimation, 2015 - 2022
10.2.2.5.3.2.Market Forecast, 2023 - 2031
10.2.2.5.4.Middle East and Africa
10.2.2.5.4.1.Market Estimation, 2015 - 2022
10.2.2.5.4.2.Market Forecast, 2023 - 2031
10.2.2.5.5.Latin America
10.2.2.5.5.1.Market Estimation, 2015 - 2022
10.2.2.5.5.2.Market Forecast, 2023 - 2031
10.2.3.Forensic Laboratories
10.2.3.1.Definition
10.2.3.2.Market Estimation and Penetration, 2015 - 2022
10.2.3.3.Market Forecast, 2023 - 2031
10.2.3.4.Compound Annual Growth Rate (CAGR)
10.2.3.5.Regional Bifurcation
10.2.3.5.1.North America
10.2.3.5.1.1.Market Estimation, 2015 - 2022
10.2.3.5.1.2.Market Forecast, 2023 - 2031
10.2.3.5.2.Europe
10.2.3.5.2.1.Market Estimation, 2015 - 2022
10.2.3.5.2.2.Market Forecast, 2023 - 2031
10.2.3.5.3.Asia Pacific
10.2.3.5.3.1.Market Estimation, 2015 - 2022
10.2.3.5.3.2.Market Forecast, 2023 - 2031
10.2.3.5.4.Middle East and Africa
10.2.3.5.4.1.Market Estimation, 2015 - 2022
10.2.3.5.4.2.Market Forecast, 2023 - 2031
10.2.3.5.5.Latin America
10.2.3.5.5.1.Market Estimation, 2015 - 2022
10.2.3.5.5.2.Market Forecast, 2023 - 2031
10.2.4.Others
10.2.4.1.Definition
10.2.4.2.Market Estimation and Penetration, 2015 - 2022
10.2.4.3.Market Forecast, 2023 - 2031
10.2.4.4.Compound Annual Growth Rate (CAGR)
10.2.4.5.Regional Bifurcation
10.2.4.5.1.North America
10.2.4.5.1.1.Market Estimation, 2015 - 2022
10.2.4.5.1.2.Market Forecast, 2023 - 2031
10.2.4.5.2.Europe
10.2.4.5.2.1.Market Estimation, 2015 - 2022
10.2.4.5.2.2.Market Forecast, 2023 - 2031
10.2.4.5.3.Asia Pacific
10.2.4.5.3.1.Market Estimation, 2015 - 2022
10.2.4.5.3.2.Market Forecast, 2023 - 2031
10.2.4.5.4.Middle East and Africa
10.2.4.5.4.1.Market Estimation, 2015 - 2022
10.2.4.5.4.2.Market Forecast, 2023 - 2031
10.2.4.5.5.Latin America
10.2.4.5.5.1.Market Estimation, 2015 - 2022
10.2.4.5.5.2.Market Forecast, 2023 - 2031
10.3.Key Segment for Channeling Investments
10.3.1.By End User
11.North America Drug of Abuse Testing Services Market Analysis and Forecasts, 2023 - 2031
11.1.Overview
11.1.1.North America Drug of Abuse Testing Services Market Revenue (US$ Mn)
11.2.North America Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
11.2.1.Pyschostimulants
11.2.2.Narcotics
11.2.3.Cannabinoids
11.2.4.Sedatives
11.2.5.Others
11.3.North America Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
11.3.1.Immunoassay
11.3.2.Chromatography
11.3.3.Rapid Testing
11.4.North America Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
11.4.1.Hospitals
11.4.2.Diagnostics Laboratories
11.4.3.Forensic Laboratories
11.4.4.Others
11.5.North America Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Country
11.5.1.U.S
11.5.1.1.U.S Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
11.5.1.1.1.Pyschostimulants
11.5.1.1.2.Narcotics
11.5.1.1.3.Cannabinoids
11.5.1.1.4.Sedatives
11.5.1.1.5.Others
11.5.1.2.U.S Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
11.5.1.2.1.Immunoassay
11.5.1.2.2.Chromatography
11.5.1.2.3.Rapid Testing
11.5.1.3.U.S Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
11.5.1.3.1.Hospitals
11.5.1.3.2.Diagnostics Laboratories
11.5.1.3.3.Forensic Laboratories
11.5.1.3.4.Others
11.5.2.Canada
11.5.2.1.Canada Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
11.5.2.1.1.Pyschostimulants
11.5.2.1.2.Narcotics
11.5.2.1.3.Cannabinoids
11.5.2.1.4.Sedatives
11.5.2.1.5.Others
11.5.2.2.Canada Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
11.5.2.2.1.Immunoassay
11.5.2.2.2.Chromatography
11.5.2.2.3.Rapid Testing
11.5.2.3.Canada Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
11.5.2.3.1.Hospitals
11.5.2.3.2.Diagnostics Laboratories
11.5.2.3.3.Forensic Laboratories
11.5.2.3.4.Others
11.5.3.Mexico
11.5.3.1.Mexico Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
11.5.3.1.1.Pyschostimulants
11.5.3.1.2.Narcotics
11.5.3.1.3.Cannabinoids
11.5.3.1.4.Sedatives
11.5.3.1.5.Others
11.5.3.2.Mexico Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
11.5.3.2.1.Immunoassay
11.5.3.2.2.Chromatography
11.5.3.2.3.Rapid Testing
11.5.3.3.Mexico Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
11.5.3.3.1.Hospitals
11.5.3.3.2.Diagnostics Laboratories
11.5.3.3.3.Forensic Laboratories
11.5.3.3.4.Others
11.5.4.Rest of North America
11.5.4.1.Rest of North America Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
11.5.4.1.1.Pyschostimulants
11.5.4.1.2.Narcotics
11.5.4.1.3.Cannabinoids
11.5.4.1.4.Sedatives
11.5.4.1.5.Others
11.5.4.2.Rest of North America Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
11.5.4.2.1.Immunoassay
11.5.4.2.2.Chromatography
11.5.4.2.3.Rapid Testing
11.5.4.3.Rest of North America Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
11.5.4.3.1.Hospitals
11.5.4.3.2.Diagnostics Laboratories
11.5.4.3.3.Forensic Laboratories
11.5.4.3.4.Others
11.6.Key Segment for Channeling Investments
11.6.1.By Country
11.6.2.By Drug Type
11.6.3.By Technique
11.6.4.By End User
12.Europe Drug of Abuse Testing Services Market Analysis and Forecasts, 2023 - 2031
12.1.Overview
12.1.1.Europe Drug of Abuse Testing Services Market Revenue (US$ Mn)
12.2.Europe Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
12.2.1.Pyschostimulants
12.2.2.Narcotics
12.2.3.Cannabinoids
12.2.4.Sedatives
12.2.5.Others
12.3.Europe Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
12.3.1.Immunoassay
12.3.2.Chromatography
12.3.3.Rapid Testing
12.4.Europe Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
12.4.1.Hospitals
12.4.2.Diagnostics Laboratories
12.4.3.Forensic Laboratories
12.4.4.Others
12.5.Europe Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Country
12.5.1.France
12.5.1.1.France Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
12.5.1.1.1.Pyschostimulants
12.5.1.1.2.Narcotics
12.5.1.1.3.Cannabinoids
12.5.1.1.4.Sedatives
12.5.1.1.5.Others
12.5.1.2.France Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
12.5.1.2.1.Immunoassay
12.5.1.2.2.Chromatography
12.5.1.2.3.Rapid Testing
12.5.1.3.France Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
12.5.1.3.1.Hospitals
12.5.1.3.2.Diagnostics Laboratories
12.5.1.3.3.Forensic Laboratories
12.5.1.3.4.Others
12.5.2.The UK
12.5.2.1.The UK Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
12.5.2.1.1.Pyschostimulants
12.5.2.1.2.Narcotics
12.5.2.1.3.Cannabinoids
12.5.2.1.4.Sedatives
12.5.2.1.5.Others
12.5.2.2.The UK Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
12.5.2.2.1.Immunoassay
12.5.2.2.2.Chromatography
12.5.2.2.3.Rapid Testing
12.5.2.3.The UK Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
12.5.2.3.1.Hospitals
12.5.2.3.2.Diagnostics Laboratories
12.5.2.3.3.Forensic Laboratories
12.5.2.3.4.Others
12.5.3.Spain
12.5.3.1.Spain Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
12.5.3.1.1.Pyschostimulants
12.5.3.1.2.Narcotics
12.5.3.1.3.Cannabinoids
12.5.3.1.4.Sedatives
12.5.3.1.5.Others
12.5.3.2.Spain Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
12.5.3.2.1.Immunoassay
12.5.3.2.2.Chromatography
12.5.3.2.3.Rapid Testing
12.5.3.3.Spain Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
12.5.3.3.1.Hospitals
12.5.3.3.2.Diagnostics Laboratories
12.5.3.3.3.Forensic Laboratories
12.5.3.3.4.Others
12.5.4.Germany
12.5.4.1.Germany Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
12.5.4.1.1.Pyschostimulants
12.5.4.1.2.Narcotics
12.5.4.1.3.Cannabinoids
12.5.4.1.4.Sedatives
12.5.4.1.5.Others
12.5.4.2.Germany Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
12.5.4.2.1.Immunoassay
12.5.4.2.2.Chromatography
12.5.4.2.3.Rapid Testing
12.5.4.3.Germany Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
12.5.4.3.1.Hospitals
12.5.4.3.2.Diagnostics Laboratories
12.5.4.3.3.Forensic Laboratories
12.5.4.3.4.Others
12.5.5.Italy
12.5.5.1.Italy Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
12.5.5.1.1.Pyschostimulants
12.5.5.1.2.Narcotics
12.5.5.1.3.Cannabinoids
12.5.5.1.4.Sedatives
12.5.5.1.5.Others
12.5.5.2.Italy Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
12.5.5.2.1.Immunoassay
12.5.5.2.2.Chromatography
12.5.5.2.3.Rapid Testing
12.5.5.3.Italy Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
12.5.5.3.1.Hospitals
12.5.5.3.2.Diagnostics Laboratories
12.5.5.3.3.Forensic Laboratories
12.5.5.3.4.Others
12.5.6.Nordic Countries
12.5.6.1.Nordic Countries Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
12.5.6.1.1.Pyschostimulants
12.5.6.1.2.Narcotics
12.5.6.1.3.Cannabinoids
12.5.6.1.4.Sedatives
12.5.6.1.5.Others
12.5.6.2.Nordic Countries Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
12.5.6.2.1.Immunoassay
12.5.6.2.2.Chromatography
12.5.6.2.3.Rapid Testing
12.5.6.3.Nordic Countries Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
12.5.6.3.1.Hospitals
12.5.6.3.2.Diagnostics Laboratories
12.5.6.3.3.Forensic Laboratories
12.5.6.3.4.Others
12.5.6.4.Nordic Countries Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Country
12.5.6.4.1.Denmark
12.5.6.4.2.Finland
12.5.6.4.3.Iceland
12.5.6.4.4.Sweden
12.5.6.4.5.Norway
12.5.7.Benelux Union
12.5.7.1.Benelux Union Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
12.5.7.1.1.Pyschostimulants
12.5.7.1.2.Narcotics
12.5.7.1.3.Cannabinoids
12.5.7.1.4.Sedatives
12.5.7.1.5.Others
12.5.7.2.Benelux Union Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
12.5.7.2.1.Immunoassay
12.5.7.2.2.Chromatography
12.5.7.2.3.Rapid Testing
12.5.7.3.Benelux Union Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
12.5.7.3.1.Hospitals
12.5.7.3.2.Diagnostics Laboratories
12.5.7.3.3.Forensic Laboratories
12.5.7.3.4.Others
12.5.7.4.Benelux Union Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Country
12.5.7.4.1.Belgium
12.5.7.4.2.The Netherlands
12.5.7.4.3.Luxembourg
12.5.8.Rest of Europe
12.5.8.1.Rest of Europe Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
12.5.8.1.1.Pyschostimulants
12.5.8.1.2.Narcotics
12.5.8.1.3.Cannabinoids
12.5.8.1.4.Sedatives
12.5.8.1.5.Others
12.5.8.2.Rest of Europe Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
12.5.8.2.1.Immunoassay
12.5.8.2.2.Chromatography
12.5.8.2.3.Rapid Testing
12.5.8.3.Rest of Europe Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
12.5.8.3.1.Hospitals
12.5.8.3.2.Diagnostics Laboratories
12.5.8.3.3.Forensic Laboratories
12.5.8.3.4.Others
12.6.Key Segment for Channeling Investments
12.6.1.By Country
12.6.2.By Drug Type
12.6.3.By Technique
12.6.4.By End User
13.Asia Pacific Drug of Abuse Testing Services Market Analysis and Forecasts, 2023 - 2031
13.1.Overview
13.1.1.Asia Pacific Drug of Abuse Testing Services Market Revenue (US$ Mn)
13.2.Asia Pacific Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
13.2.1.Pyschostimulants
13.2.2.Narcotics
13.2.3.Cannabinoids
13.2.4.Sedatives
13.2.5.Others
13.3.Asia Pacific Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
13.3.1.Immunoassay
13.3.2.Chromatography
13.3.3.Rapid Testing
13.4.Asia Pacific Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
13.4.1.Hospitals
13.4.2.Diagnostics Laboratories
13.4.3.Forensic Laboratories
13.4.4.Others
13.5.Asia Pacific Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Country
13.5.1.China
13.5.1.1.China Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
13.5.1.1.1.Pyschostimulants
13.5.1.1.2.Narcotics
13.5.1.1.3.Cannabinoids
13.5.1.1.4.Sedatives
13.5.1.1.5.Others
13.5.1.2.China Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
13.5.1.2.1.Immunoassay
13.5.1.2.2.Chromatography
13.5.1.2.3.Rapid Testing
13.5.1.3.China Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
13.5.1.3.1.Hospitals
13.5.1.3.2.Diagnostics Laboratories
13.5.1.3.3.Forensic Laboratories
13.5.1.3.4.Others
13.5.2.Japan
13.5.2.1.Japan Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
13.5.2.1.1.Pyschostimulants
13.5.2.1.2.Narcotics
13.5.2.1.3.Cannabinoids
13.5.2.1.4.Sedatives
13.5.2.1.5.Others
13.5.2.2.Japan Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
13.5.2.2.1.Immunoassay
13.5.2.2.2.Chromatography
13.5.2.2.3.Rapid Testing
13.5.2.3.Japan Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
13.5.2.3.1.Hospitals
13.5.2.3.2.Diagnostics Laboratories
13.5.2.3.3.Forensic Laboratories
13.5.2.3.4.Others
13.5.3.India
13.5.3.1.India Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
13.5.3.1.1.Pyschostimulants
13.5.3.1.2.Narcotics
13.5.3.1.3.Cannabinoids
13.5.3.1.4.Sedatives
13.5.3.1.5.Others
13.5.3.2.India Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
13.5.3.2.1.Immunoassay
13.5.3.2.2.Chromatography
13.5.3.2.3.Rapid Testing
13.5.3.3.India Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
13.5.3.3.1.Hospitals
13.5.3.3.2.Diagnostics Laboratories
13.5.3.3.3.Forensic Laboratories
13.5.3.3.4.Others
13.5.4.New Zealand
13.5.4.1.New Zealand Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
13.5.4.1.1.Pyschostimulants
13.5.4.1.2.Narcotics
13.5.4.1.3.Cannabinoids
13.5.4.1.4.Sedatives
13.5.4.1.5.Others
13.5.4.2.New Zealand Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
13.5.4.2.1.Immunoassay
13.5.4.2.2.Chromatography
13.5.4.2.3.Rapid Testing
13.5.4.3.New Zealand Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
13.5.4.3.1.Hospitals
13.5.4.3.2.Diagnostics Laboratories
13.5.4.3.3.Forensic Laboratories
13.5.4.3.4.Others
13.5.5.Australia
13.5.5.1.Australia Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
13.5.5.1.1.Pyschostimulants
13.5.5.1.2.Narcotics
13.5.5.1.3.Cannabinoids
13.5.5.1.4.Sedatives
13.5.5.1.5.Others
13.5.5.2.Australia Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
13.5.5.2.1.Immunoassay
13.5.5.2.2.Chromatography
13.5.5.2.3.Rapid Testing
13.5.5.3.Australia Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
13.5.5.3.1.Hospitals
13.5.5.3.2.Diagnostics Laboratories
13.5.5.3.3.Forensic Laboratories
13.5.5.3.4.Others
13.5.6.South Korea
13.5.6.1.South Korea Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
13.5.6.1.1.Pyschostimulants
13.5.6.1.2.Narcotics
13.5.6.1.3.Cannabinoids
13.5.6.1.4.Sedatives
13.5.6.1.5.Others
13.5.6.2.South Korea Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
13.5.6.2.1.Immunoassay
13.5.6.2.2.Chromatography
13.5.6.2.3.Rapid Testing
13.5.6.3.South Korea Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
13.5.6.3.1.Hospitals
13.5.6.3.2.Diagnostics Laboratories
13.5.6.3.3.Forensic Laboratories
13.5.6.3.4.Others
13.5.7.Southeast Asia
13.5.7.1.Southeast Asia Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
13.5.7.1.1.Pyschostimulants
13.5.7.1.2.Narcotics
13.5.7.1.3.Cannabinoids
13.5.7.1.4.Sedatives
13.5.7.1.5.Others
13.5.7.2.Southeast Asia Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
13.5.7.2.1.Immunoassay
13.5.7.2.2.Chromatography
13.5.7.2.3.Rapid Testing
13.5.7.3.Southeast Asia Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
13.5.7.3.1.Hospitals
13.5.7.3.2.Diagnostics Laboratories
13.5.7.3.3.Forensic Laboratories
13.5.7.3.4.Others
13.5.7.4.Southeast Asia Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Country
13.5.7.4.1.Indonesia
13.5.7.4.2.Thailand
13.5.7.4.3.Malaysia
13.5.7.4.4.Singapore
13.5.7.4.5.Rest of Southeast Asia
13.5.8.Rest of Asia Pacific
13.5.8.1.Rest of Asia Pacific Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
13.5.8.1.1.Pyschostimulants
13.5.8.1.2.Narcotics
13.5.8.1.3.Cannabinoids
13.5.8.1.4.Sedatives
13.5.8.1.5.Others
13.5.8.2.Rest of Asia Pacific Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
13.5.8.2.1.Immunoassay
13.5.8.2.2.Chromatography
13.5.8.2.3.Rapid Testing
13.5.8.3.Rest of Asia Pacific Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
13.5.8.3.1.Hospitals
13.5.8.3.2.Diagnostics Laboratories
13.5.8.3.3.Forensic Laboratories
13.5.8.3.4.Others
13.6.Key Segment for Channeling Investments
13.6.1.By Country
13.6.2.By Drug Type
13.6.3.By Technique
13.6.4.By End User
14.Middle East and Africa Drug of Abuse Testing Services Market Analysis and Forecasts, 2023 - 2031
14.1.Overview
14.1.1.Middle East and Africa Drug of Abuse Testing Services Market Revenue (US$ Mn)
14.2.Middle East and Africa Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
14.2.1.Pyschostimulants
14.2.2.Narcotics
14.2.3.Cannabinoids
14.2.4.Sedatives
14.2.5.Others
14.3.Middle East and Africa Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
14.3.1.Immunoassay
14.3.2.Chromatography
14.3.3.Rapid Testing
14.4.Middle East and Africa Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
14.4.1.Hospitals
14.4.2.Diagnostics Laboratories
14.4.3.Forensic Laboratories
14.4.4.Others
14.5.Middle East and Africa Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Country
14.5.1.Saudi Arabia
14.5.1.1.Saudi Arabia Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
14.5.1.1.1.Pyschostimulants
14.5.1.1.2.Narcotics
14.5.1.1.3.Cannabinoids
14.5.1.1.4.Sedatives
14.5.1.1.5.Others
14.5.1.2.Saudi Arabia Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
14.5.1.2.1.Immunoassay
14.5.1.2.2.Chromatography
14.5.1.2.3.Rapid Testing
14.5.1.3.Saudi Arabia Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
14.5.1.3.1.Hospitals
14.5.1.3.2.Diagnostics Laboratories
14.5.1.3.3.Forensic Laboratories
14.5.1.3.4.Others
14.5.2.UAE
14.5.2.1.UAE Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
14.5.2.1.1.Pyschostimulants
14.5.2.1.2.Narcotics
14.5.2.1.3.Cannabinoids
14.5.2.1.4.Sedatives
14.5.2.1.5.Others
14.5.2.2.UAE Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
14.5.2.2.1.Immunoassay
14.5.2.2.2.Chromatography
14.5.2.2.3.Rapid Testing
14.5.2.3.UAE Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
14.5.2.3.1.Hospitals
14.5.2.3.2.Diagnostics Laboratories
14.5.2.3.3.Forensic Laboratories
14.5.2.3.4.Others
14.5.3.Egypt
14.5.3.1.Egypt Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
14.5.3.1.1.Pyschostimulants
14.5.3.1.2.Narcotics
14.5.3.1.3.Cannabinoids
14.5.3.1.4.Sedatives
14.5.3.1.5.Others
14.5.3.2.Egypt Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
14.5.3.2.1.Immunoassay
14.5.3.2.2.Chromatography
14.5.3.2.3.Rapid Testing
14.5.3.3.Egypt Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
14.5.3.3.1.Hospitals
14.5.3.3.2.Diagnostics Laboratories
14.5.3.3.3.Forensic Laboratories
14.5.3.3.4.Others
14.5.4.Kuwait
14.5.4.1.Kuwait Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
14.5.4.1.1.Pyschostimulants
14.5.4.1.2.Narcotics
14.5.4.1.3.Cannabinoids
14.5.4.1.4.Sedatives
14.5.4.1.5.Others
14.5.4.2.Kuwait Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
14.5.4.2.1.Immunoassay
14.5.4.2.2.Chromatography
14.5.4.2.3.Rapid Testing
14.5.4.3.Kuwait Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
14.5.4.3.1.Hospitals
14.5.4.3.2.Diagnostics Laboratories
14.5.4.3.3.Forensic Laboratories
14.5.4.3.4.Others
14.5.5.South Africa
14.5.5.1.South Africa Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
14.5.5.1.1.Pyschostimulants
14.5.5.1.2.Narcotics
14.5.5.1.3.Cannabinoids
14.5.5.1.4.Sedatives
14.5.5.1.5.Others
14.5.5.2.South Africa Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
14.5.5.2.1.Immunoassay
14.5.5.2.2.Chromatography
14.5.5.2.3.Rapid Testing
14.5.5.3.South Africa Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
14.5.5.3.1.Hospitals
14.5.5.3.2.Diagnostics Laboratories
14.5.5.3.3.Forensic Laboratories
14.5.5.3.4.Others
14.5.6.Rest of Middle East & Africa
14.5.6.1.Rest of Middle East & Africa Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
14.5.6.1.1.Pyschostimulants
14.5.6.1.2.Narcotics
14.5.6.1.3.Cannabinoids
14.5.6.1.4.Sedatives
14.5.6.1.5.Others
14.5.6.2.Rest of Middle East & Africa Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
14.5.6.2.1.Immunoassay
14.5.6.2.2.Chromatography
14.5.6.2.3.Rapid Testing
14.5.6.3.Rest of Middle East & Africa Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
14.5.6.3.1.Hospitals
14.5.6.3.2.Diagnostics Laboratories
14.5.6.3.3.Forensic Laboratories
14.5.6.3.4.Others
14.6.Key Segment for Channeling Investments
14.6.1.By Country
14.6.2.By Drug Type
14.6.3.By Technique
14.6.4.By End User
15.Latin America Drug of Abuse Testing Services Market Analysis and Forecasts, 2023 - 2031
15.1.Overview
15.1.1.Latin America Drug of Abuse Testing Services Market Revenue (US$ Mn)
15.2.Latin America Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
15.2.1.Pyschostimulants
15.2.2.Narcotics
15.2.3.Cannabinoids
15.2.4.Sedatives
15.2.5.Others
15.3.Latin America Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
15.3.1.Immunoassay
15.3.2.Chromatography
15.3.3.Rapid Testing
15.4.Latin America Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
15.4.1.Hospitals
15.4.2.Diagnostics Laboratories
15.4.3.Forensic Laboratories
15.4.4.Others
15.5.Latin America Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Country
15.5.1.Brazil
15.5.1.1.Brazil Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
15.5.1.1.1.Pyschostimulants
15.5.1.1.2.Narcotics
15.5.1.1.3.Cannabinoids
15.5.1.1.4.Sedatives
15.5.1.1.5.Others
15.5.1.2.Brazil Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
15.5.1.2.1.Immunoassay
15.5.1.2.2.Chromatography
15.5.1.2.3.Rapid Testing
15.5.1.3.Brazil Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
15.5.1.3.1.Hospitals
15.5.1.3.2.Diagnostics Laboratories
15.5.1.3.3.Forensic Laboratories
15.5.1.3.4.Others
15.5.2.Argentina
15.5.2.1.Argentina Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
15.5.2.1.1.Pyschostimulants
15.5.2.1.2.Narcotics
15.5.2.1.3.Cannabinoids
15.5.2.1.4.Sedatives
15.5.2.1.5.Others
15.5.2.2.Argentina Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
15.5.2.2.1.Immunoassay
15.5.2.2.2.Chromatography
15.5.2.2.3.Rapid Testing
15.5.2.3.Argentina Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
15.5.2.3.1.Hospitals
15.5.2.3.2.Diagnostics Laboratories
15.5.2.3.3.Forensic Laboratories
15.5.2.3.4.Others
15.5.3.Rest of Latin America
15.5.3.1.Rest of Latin America Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Drug Type
15.5.3.1.1.Pyschostimulants
15.5.3.1.2.Narcotics
15.5.3.1.3.Cannabinoids
15.5.3.1.4.Sedatives
15.5.3.1.5.Others
15.5.3.2.Rest of Latin America Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By Technique
15.5.3.2.1.Immunoassay
15.5.3.2.2.Chromatography
15.5.3.2.3.Rapid Testing
15.5.3.3.Rest of Latin America Drug of Abuse Testing Services Market Revenue (US$ Mn) and Forecasts, By End User
15.5.3.3.1.Hospitals
15.5.3.3.2.Diagnostics Laboratories
15.5.3.3.3.Forensic Laboratories
15.5.3.3.4.Others
15.6.Key Segment for Channeling Investments
15.6.1.By Country
15.6.2.By Drug Type
15.6.3.By Technique
15.6.4.By End User
16.Competitive Benchmarking
16.1.Brand Benchmarking
16.2.Market Share Analysis, 2022
16.3.Global Presence and Growth Strategies
16.3.1.Mergers and Acquisitions
16.3.2.Product Launches
16.3.3.Investments Trends
16.3.4.R&D Initiatives
17.Player Profiles
17.1.Abbott
17.1.1.Company Details
17.1.2.Company Overview
17.1.3.Product Offerings
17.1.4.Key Developments
17.1.5.Financial Analysis
17.1.6.SWOT Analysis
17.1.7.Business Strategies
17.2.American Substance Abuse Professionals, Inc.
17.2.1.Company Details
17.2.2.Company Overview
17.2.3.Product Offerings
17.2.4.Key Developments
17.2.5.Financial Analysis
17.2.6.SWOT Analysis
17.2.7.Business Strategies
17.3.Clinical Reference Laboratory, Inc.
17.3.1.Company Details
17.3.2.Company Overview
17.3.3.Product Offerings
17.3.4.Key Developments
17.3.5.Financial Analysis
17.3.6.SWOT Analysis
17.3.7.Business Strategies
17.4.Cordant Health Solutions
17.4.1.Company Details
17.4.2.Company Overview
17.4.3.Product Offerings
17.4.4.Key Developments
17.4.5.Financial Analysis
17.4.6.SWOT Analysis
17.4.7.Business Strategies
17.5.DRUGSCAN
17.5.1.Company Details
17.5.2.Company Overview
17.5.3.Product Offerings
17.5.4.Key Developments
17.5.5.Financial Analysis
17.5.6.SWOT Analysis
17.5.7.Business Strategies
17.6.Laboratory Corporation of America Holdings
17.6.1.Company Details
17.6.2.Company Overview
17.6.3.Product Offerings
17.6.4.Key Developments
17.6.5.Financial Analysis
17.6.6.SWOT Analysis
17.6.7.Business Strategies
17.7.Legacy Medical Services, LLC
17.7.1.Company Details
17.7.2.Company Overview
17.7.3.Product Offerings
17.7.4.Key Developments
17.7.5.Financial Analysis
17.7.6.SWOT Analysis
17.7.7.Business Strategies
17.8.LGC Limited
17.8.1.Company Details
17.8.2.Company Overview
17.8.3.Product Offerings
17.8.4.Key Developments
17.8.5.Financial Analysis
17.8.6.SWOT Analysis
17.8.7.Business Strategies
17.9.Mayo Foundation for Medical Education and Research
17.9.1.Company Details
17.9.2.Company Overview
17.9.3.Product Offerings
17.9.4.Key Developments
17.9.5.Financial Analysis
17.9.6.SWOT Analysis
17.9.7.Business Strategies
17.10.Millennium Health
17.10.1.Company Details
17.10.2.Company Overview
17.10.3.Product Offerings
17.10.4.Key Developments
17.10.5.Financial Analysis
17.10.6.SWOT Analysis
17.10.7.Business Strategies
17.11.Omega Laboratories, Inc.
17.11.1.Company Details
17.11.2.Company Overview
17.11.3.Product Offerings
17.11.4.Key Developments
17.11.5.Financial Analysis
17.11.6.SWOT Analysis
17.11.7.Business Strategies
17.12.Precision Diagnostics
17.12.1.Company Details
17.12.2.Company Overview
17.12.3.Product Offerings
17.12.4.Key Developments
17.12.5.Financial Analysis
17.12.6.SWOT Analysis
17.12.7.Business Strategies
17.13.Psychemedics Corporation
17.13.1.Company Details
17.13.2.Company Overview
17.13.3.Product Offerings
17.13.4.Key Developments
17.13.5.Financial Analysis
17.13.6.SWOT Analysis
17.13.7.Business Strategies
17.14.Quest Diagnostics
17.14.1.Company Details
17.14.2.Company Overview
17.14.3.Product Offerings
17.14.4.Key Developments
17.14.5.Financial Analysis
17.14.6.SWOT Analysis
17.14.7.Business Strategies
17.15.United States Drug Testing Laboratories, Inc.
17.15.1.Company Details
17.15.2.Company Overview
17.15.3.Product Offerings
17.15.4.Key Developments
17.15.5.Financial Analysis
17.15.6.SWOT Analysis
17.15.7.Business Strategies
17.16.Other Industry Participants
18.Key Findings

.

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion

**Exclusive for Multi-User and Enterprise User.

Global Drug of Abuse Testing Services Market

By Drug Type

 Pyschostimulants
 Narcotic
 Cannabinoids
 Sedatives
 Others

By Technique

 Immunoassay
 Chromatography
 Rapid Testing

By End User

 Hospitals
 Diagnostics Laboratories
 Forensic Laboratories
 Others

By Region

 North America (U.S., Canada, Mexico, Rest of North America)
 Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)
 Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
 Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
 Latin America (Brazil, Argentina, Rest of Latin America)

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion

**Exclusive for Multi-User and Enterprise User.

.

The Niche Research approach encompasses both primary and secondary research methods to provide comprehensive insights. While primary research is the cornerstone of our studies, we also incorporate secondary research sources such as company annual reports, premium industry databases, press releases, industry journals, and white papers. Within our primary research, we actively engage with various industry stakeholders, conducting paid interviews and surveys. Our meticulous analysis extends to every market participant in major countries, allowing us to thoroughly examine their portfolios, calculate market shares, and segment revenues. Our data collection primarily focuses on individual countries within our research scope, enabling us to estimate regional market sizes. Typically, we employ a bottom-up approach, meticulously tracking trends in different countries. We analyze growth drivers, constraints, technological innovations, and opportunities for each country, ultimately arriving at regional figures.Our process begins by examining the growth prospects of each country. Building upon these insights, we project growth and trends for the entire region. Finally, we utilize our proprietary model to refine estimations and forecasts. Our data validation standards are integral to ensuring the reliability and accuracy of our research findings. Here's a breakdown of our data validation processes and the stakeholders we engage with during our primary research:
  • Supply Side Analysis: We initiate a supply side analysis by directly contacting market participants, through telephonic interviews and questionnaires containing both open-ended and close-ended questions. We gather information on their portfolios, segment revenues, developments, and growth strategies.
  • Demand Side Analysis: To gain insights into adoption trends and consumer preferences, we reach out to target customers and users (non-vendors). This information forms a vital part of the qualitative analysis section of our reports, covering market dynamics, adoption trends, consumer behavior, spending patterns, and other related aspects.
  • Consultant Insights: We tap into the expertise of our partner consultants from around the world to obtain their unique viewpoints and perspectives. Their insights contribute to a well-rounded understanding of the markets under investigation.
  • In-House Validation: To ensure data accuracy and reliability, we conduct cross-validation of data points and information through our in-house team of consultants and utilize advanced data modeling tools for thorough verification.
The forecasts we provide are based on a comprehensive assessment of various factors, including:
  • Market Trends and Past Performance (Last Five Years): We accurately analyze market trends and performance data from preceding five years to identify historical patterns and understand the market's evolution.
  • Historical Performance and Growth of Market Participants: We assess the historical performance and growth trajectories of key market participants. This analysis provides insights into the competitive landscape and individual company strategies.
  • Market Determinants Impact Analysis (Next Eight Years): We conduct a rigorous analysis of the factors that are projected to influence the market over the next eight years. This includes assessing both internal and external determinants that can shape market dynamics.
  • Drivers and Challenges for the Forecast Period:Identify the factors expected to drive market growth during the forecast period, as well as the challenges that the industry may face. This analysis aids in deriving an accurate growth rate projection.
  • New Acquisitions, Collaborations, or Partnerships: We keep a close watch on any new acquisitions, collaborations, or partnerships within the industry. These developments can have a significant impact on market dynamics and competitiveness.
  • Macro and Micro Factors Analysis:A thorough examination of both macro-level factors (e.g., economic trends, regulatory changes) and micro-level factors (e.g., technological advancements, consumer preferences) that may influence the market during the forecast period.
  • End-User Sentiment Analysis: To understand the market from the end-user perspective, we conduct sentiment analysis. This involves assessing the sentiment, preferences, and feedback of the end-users, which can provide valuable insights into market trends.
  • Perspective of Primary Participants: Insights gathered directly from primary research participants play a crucial role in shaping our forecasts. Their perspectives and experiences provide valuable qualitative data.
  • Year-on-Year Growth Trend: We utilize a year-on-year growth trend based on historical market growth and expected future trends. This helps in formulating our growth projections, aligning them with the market's historical performance.
Research process adopted by TNR involves multiple stages, including data collection, validation, quality checks, and presentation. It's crucial that the data and information we provide add value to your existing market understanding and expertise. We have also established partnerships with business consulting, research, and survey organizations across regions and globally to collaborate on regional analysis and data validation, ensuring the highest level of accuracy and reliability in our reports.    

Procure Comprehensive Study of

Global Drug of Abuse Testing Services Market

Online Only

  • Online Access
  • Read Only File
  • Validity 3 Months
  • Print, Copy, Paste & Download
  • PPT, Excel
  • Cost-Free Report in the Next Update
$3300
Buy Now

Single User

  • Access to One User on One System
  • Read Only File
  • Validity 6 Months
  • Limited Print,Copy, Paste
  • PPT, Excel
  • Cost-Free Report in the Next Update
$4200
Buy Now

Multi User

  • Access to Fiver Users
  • PDF File
  • Validity 1 Year
  • Upto FivePrints
  • Cost-Free Report in the Next Update
  • PPT, Excel
$6000
Buy Now

Enterprise User

  • Access to Unlimited Users
  • PDF, PPT, Excel
  • Unlimited Validity, Prints&Downloads
  • 1 Hour Cost-Free & Dedicated Analyst Support
  • 10% Cost-Free Customization
  • Cost-Free Report Update Twice in a Year
  • Recommendations for Business Strategies
  • Authorization to Quote TNR, The Niche Research
$7300
Buy Now

Library Access

  • Online Access to Content Publications
  • Access Player Profiles Online
  • Get Immediate Access to Newly Added Content
  • Acquire 12 PDF Downloads
  • Acquire 5 Excel Data Sets
  • Gain Access to 290+ PDFs of Company Profiles
  • Round-the-clock Email and Phone Assistance
  • Dashboard Usage and Trends
  • Renewal & Upgrade Assistance
  • Assessing Customization Options and Alerts for New Reports
$10788
Buy Now
*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Why TNR The Niche Research?

  • Unwavering Commitment to Excellence

  • Veteran Team of Researchers

  • Accurate and Timely Insights

  • Ethical Practices and Customized Service

  • Uninterrupted Availability Around the Clock

Scroll to Top